US Site
Alcon Site Directory
Patients and Caregivers
Our Science
Theragnostic Platform
Nuclear Medicine
Our Pipeline
Clinical Trials
Scientific Publications and Presentations
Managed Access Programs
Our Focus
Prostate Cancer
Neuroendocrine Cancer
Our Company
Our Business
Our Sites
History
Ethics, Risk and Compliance
AAA External Funding
Our Products
News
Press Release
Contact Us
Our Pipeline
Clinical Trials
Coronavirus
Careers
English
Deutsch
(
German
)
Français
(
French
)
Italiano
(
Italian
)
Español
(
Spanish
)
AAA acquires rights to oncology antibody treatment FabOvar from Dompé
×
Work in progress